Business Context and Reporting Period
Incannex Healthcare Limited, an Australian foreign private issuer, filed Form 6-K for September 2022 under Commission File No. 001-41106. The filing reports an Australian Securities Exchange announcement dated September 6, 2022, titled “Incannex Included in the S&P/ASX 300 Index.”
Financial and Operating Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes Versus Prior Period
The filing describes the company’s inclusion in the S&P/ASX 300 Index. No quantitative comparison with a prior period or additional operating change is provided.
Guidance, Outlook, Risks, and Unusual Items
No financial guidance, outlook, management commentary, risks, contingencies, or unusual accounting items are included in the provided filing text. The referenced ASX announcement is attached as Exhibit 99.1, but its substantive contents are not included in the source text.
Key Facts to Verify
- Confirm the effective date and basis for Incannex’s inclusion in the S&P/ASX 300 Index.
- Review Exhibit 99.1 for any additional company commentary or market-index details.
- Obtain the company’s applicable financial statements or subsequent filings to assess financial performance, liquidity, debt, and cash runway.